Cardiovascular • May 1-3, 2017
Boston, MA • United States

Highlights

First Look

The Next Wave of Cardiovascular Breakthroughs

First Look

Monday | May 1, 2017 | 8AM

Early career Harvard Medical School investigators kick-off the World Medical Innovation Forum with rapid fire presentations of their high potential new technologies. Nineteen rising stars from Brigham Health and Massachusetts General Hospital will highlight in ten-minute presentations their discoveries and insights that will be the disruptive cardiovascular care of the future. This session is designed for investors, leaders, donors, entrepreneurs and investigators and others who share a passion for identifying emerging high-impact technologies. The top presenter each from BWH and MGH will be awarded the Austen-Braunwald Innovation Prize on Day 2 of the Forum. The prize carries a $10,000 award.

Novel Target Discovery Pipeline for Calcific Aortic Valve Disease
Elena Aikawa, MD, PhD
Director, Heart Valve Translational Research Program, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School

A zebrafish pipeline for cardiovascular precision medicine
Manu Beerens, PhD
Postdoctoral Research Fellow, Brigham and Women's Hospital; Harvard Medical School

Using zebrafish to understand and harness cardiac regeneration
Caroline Burns, PhD
Associate Biologist, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School

Bioactive Lipid Profiling Can Identify Potential Targets for Altering Life Course Trajectories Toward Cardiometabolic Disease
Susan Cheng, MD
Associate Physician, Brigham and Women's Hospital, Partners HealthCare; Assistant Professor, Harvard Medical School

Small Molecule Predictors of Outcome After Cardiac Interventions
Sammy Elmariah, MD
Assistant in Medicine, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School

Translational trials in microRNAs
Mark Feinberg, MD
Physician, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School

New approaches to controlling stem cell fate
Yick Fong, PhD
Research Scientist, Brigham and Women's Hospital; Assistant Professor of Medicine, Harvard Medical School

Exercise Prescription to Improve Cardiovascular and Cancer Outcomes in Cancer Survivors
John Groarke, MD
Cardiologist, Brigham and Women's Hospital; Instructor of Medicine, Harvard Medical

Personalizing Diabetic Management with Hemoglobin A1c
John Higgins, MD
Associate Pathologist, Massachusetts General Hospital; Associate Professor, Harvard Medical School

Characterizing an Early HFpEF Phenotype: Cardiometabolic Disease and Pulmonary Hypertension
Jennifer Ho, MD
Assistant Physician, Massachusetts General Hospital; Member of the Faculty of Medicine, Harvard Medical School

Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
Amit Khera, MD
Cardiologist, Massachusetts General Hospital; Instructor, Harvard Medical School

A Novel Epigenetic Complex Implicated in Thoracic Aortic Aneurysm (TAA)
Mark Lindsay, MD, PhD
Physician, Massachusetts General Hospital; Assistant Professor, Harvard Medical School

Atrial Fibrillation: Genetic Basis and Clinical Implications
Steven Lubitz, MD
Cardiac Electrophysiologist, Massachusetts General Hospital

Targeting Vascular Calcification to Prevent Cardiovascular Disease
Rajeev Malhotra, MD
Staff Cardiologist, Associate Medical Director of the Cardiac Intensive Care Unit, Associate Director of the Cardiopulmonary Exercise Laboratory, Massachusetts General Hospital; Instructor in Medicine, Harvard Medical School\

Stratifying Exercise Dysfunction
Bradley Maron, MD
Association Physician, Brigham and Women's Hospital; Assistant Professor, Harvard Medical School

Novel Mouse Models of Remote Cardioprotection
Benjamin Olenchock, MD, PhD
Cardiovascular Medicine Specialist, Brigham and Women's Hospital; Instructor in Medicine, Harvard Medical School

Harnessing Endogenous Mechanisms of Programmed Gene Expression for Therapeutic Benefit In Cardiometabolic Disorders
Jorge Plutzky, MD
Director, Preventive Cardiology, Cardiovascular Medicine, Brigham and Women's Hospital

Aging and the activin type II receptor pathway: a new target for heart failure therapy?
Jason Roh, MD
Assistant in Medicine, Massachusetts General Hospital; Instructor, Harvard Medical School

Signaling and pulmonary vascular disease
Paul Yu, MD, PhD
Physician, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School

 

2016 World Forum First Look Book | Cancer

Discovery Café Workshops

Lunch with Top Cardiovascular Leadership from across Partners HealthCare

Monday | May 1, 2017 | 11:45 AM

Seven intensive workshops led by our top faculty will address cutting-edge cardiovascular topics. Seating is reserved at the point of registration. Lunch included.

Panels

Cardiac Replacement Therapy: The Next Ten Years- Great Republic | 7th Floor

  • Introducer: Seema Basu, PhD, Market Sector Leader, Partners HealthCare
  • Garrick Stewart, MD, Associate Physician, Medical Director, Mechanical Circulatory Support Unit, Brigham and Women’s Hospital; Instructor in Medicine, Harvard Medical School
  • Erin Coglianese, MDMedical Director, Mechanical Cardiac Support Program, Massachusetts General Hospital

Heart Failure: Back in The Game through New Pathways- Essex North | 3rd Floor

  • Introducer: Dan Castro, Managing Director, Licensing, Partners HealthCare
  • Anju Nohria, MDDirector, Cardio-Oncology Program, Cardiovascular Medicine Specialist, Brigham and Women’s Hospital
  • Christopher Newton-Cheh, MDCardiologist, Heart Failure and Transplantation, Massachusetts General Hospital

Payment Models: Provider’s Perspective- North Star | 7th Floor

  • Introducer: Sepideh Hashemi, Market Sector Leader, Partners HealthCare
  • Thomas Gaziano, MD, Associate Physician, Cardiovascular Medicine, Brigham and Women’s Hospital; Assistant Professor, Harvard Medical School
  • Jason Wasfy, MD, Assistant Medical Director, Massachusetts General Hospital; Assistant Professor, Harvard Medical School

Molecular and Advanced Imaging: New Biological Endpoints – Function Over Structure- Baltic | 7th Floor

  • Introducer: Glenn Miller, PhD, Market Sector Leader, Partners HealthCare
  • Marcelo Di Carli, MDChief, Division of Nuclear Medicine and Molecular Imaging, Brigham and Women’s Hospital; Professor of Radiology and Medicine, Harvard Medical School
  • Farouc Jaffer, MD, PhDDirector, Coronary Intervention, Cardiac Catheterization Laboratory, Cardiology Division, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School
  • Sharmila Dorbala, MD, Director, Nuclear Cardiology, Brigham and Women's Hospital; Associate Professor of Radiology, Harvard Medical School

Open Innovation in Medical Devices: What is it? What Are the Barriers?- Essex South | 3rd Floor

  • Introducer: Pat Fortune, PhD, Vice President for Market Sectors, Partners HealthCare
  • Elazer Edelman, MD, PhDSenior Attending Physician, Brigham and Women’s Hospital; Professor of Medicine, Harvard Medical School; Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology, MIT
  • Bruce Rosengard, MD, Chief Medical Science and Technology Officer, Johnson & Johnson Medical Devices Companies
  • Ronald Tompkins, MD, Director, Surgery, Innovation & Bioengineering, Massachusetts General Hospital; Sumner M. Redstone Professor of Surgery, Harvard Medical School

Wearables for Cardiovascular Health:  How to Validate and Integrate in Care Paths?- Parliament/Adams | 7th Floor

  • Introducer: Thomas Aretz, MD, Vice President, Global Programs, Partners HealthCare
  • David Levine, MDHome Hospital Director, Brigham and Women’s Hospital; Fellow in General Internal Medicine, Harvard Medical School
  • Kamal Jethwani, MDSenior Director, Connected Health Innovation, Partners HealthCare; Assistant Professor, Dermatology, Harvard Medical School
  • Paolo Bonato, PhD, Director, Motion Analysis Laboratory, Spaulding Hospital; Associate Professor, Harvard Medical School

Image Based Artificial Intelligence: Which Cardiac Disease Segments and Why?  Empire | 7th Floor

  • Introducer: Trung Do, Vice President, Business Development, Partners HealthCare
  • George Washko, MDAssociate Physician, Brigham and Women’s Hospital; Associate Professor of Medicine, Harvard Medical School
  • Mark Michalski, MDDirector, CCDS, Brigham and Women’s Hospital, Massachusetts General Hospital

Disruptive Dozen

Celebrate the Selection of the 12 Most Disruptive Technologies in Cardiovascular Care

Disruptive Dozen LogoWednesday | May 3, 2017 | NOON

Harvard faculty from Brigham and Women’s Hospital and Massachusetts General Hospital select the technologies that will have the greatest impact on cardiovascular and cardiometabolic care in the next decade. The top 12 will be announced by a panel of BWH and MGH clinical experts.

Click here to view (2015) Neuroscience and (2016) Cancer Disruptive Dozen Awardees.